EYPT icon

EyePoint Pharmaceuticals
EYPT

Overview Fund Activity

26 hedge funds and large institutions have $12.4M invested in EyePoint Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
26
Holders Change
+26
Holders Change %
–
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
–
Reduced
–
Closed
–
Calls
$565K
Puts
$260K
Net Calls
+$305K
Net Calls Change
+$305K

Top Buyers

1
NRC
1
North Run Capital
Massachusetts
$6.2M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.32M
3
Morgan Stanley
3
Morgan Stanley
New York
$1.06M
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$995K
5
BCM
5
Bridgeway Capital Management
Texas
$399K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
– – – –
Group One Trading
27
Group One Trading
Illinois
– – – –
Bank of America
28
Bank of America
North Carolina
$0 24 +24 New
1
2